Andresen G V, Birch L L, Johnson P A
Department of Psychology, University of Illinois, Urbana.
Cancer. 1990 Oct 1;66(7):1649-53. doi: 10.1002/1097-0142(19901001)66:7<1649::aid-cncr2820660733>3.0.co;2-7.
The effects of consuming a novel food (halva) versus a familiar food (cookies) before gastrointestinal (GI) toxic chemotherapy on patients' preference for familiar foods consumed after chemotherapy treatment were compared. The development of aversions to the novel and familiar foods was also assessed. Patients with a history of posttreatment nausea consumed either a novel or a familiar food before chemotherapy and were asked to keep a food record through the next breakfast and to rate their preference for these foods. Patients who consumed halva before treatment were significantly more likely to increase their ratings for foods consumed after chemotherapy than patients who consumed familiar cookies. Aversions to the novel food were significantly more frequent than aversions to the familiar food. These findings provide evidence that a novel but not a familiar food consumed before chemotherapy can act as a scapegoat to prevent items in the regular diet consumed after chemotherapy from decreasing in preference. Providing patients with a novel food before chemotherapy is a useful clinical intervention to reduce the likelihood of forming aversions to familiar foods consumed after chemotherapy.
比较了在胃肠道毒性化疗前食用新型食物（哈瓦那糖）与熟悉食物（饼干）对患者化疗后食用熟悉食物的偏好的影响。还评估了对新型和熟悉食物厌恶情绪的发展。有治疗后恶心病史的患者在化疗前食用新型或熟悉的食物，并被要求记录下一顿早餐前的食物记录，并对这些食物的偏好进行评分。与食用熟悉饼干的患者相比，治疗前食用哈瓦那糖的患者在化疗后对食物的评分显著增加。对新型食物的厌恶比熟悉食物的厌恶更为频繁。这些发现提供了证据，表明化疗前食用新型而非熟悉的食物可以充当替罪羊，以防止化疗后常规饮食中的食物偏好降低。化疗前为患者提供新型食物是一种有用的临床干预措施，可降低化疗后对熟悉食物产生厌恶的可能性。
